LEFTY1
Basic information
Region (hg38): 1:225886282-225911382
Previous symbols: [ "LEFTB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LEFTY1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 43 | 50 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 6 | 4 |
Variants in LEFTY1
This is a list of pathogenic ClinVar variants found in the LEFTY1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-225886749-A-C | not specified | Uncertain significance (Jun 07, 2024) | ||
1-225886773-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
1-225886830-C-G | not specified | Uncertain significance (Jan 24, 2023) | ||
1-225886860-G-A | not specified | Uncertain significance (May 04, 2022) | ||
1-225886863-T-G | Benign (Jan 10, 2019) | |||
1-225886878-A-T | not specified | Uncertain significance (May 29, 2024) | ||
1-225886880-G-A | Likely benign (Oct 23, 2018) | |||
1-225886889-A-C | Likely benign (Oct 23, 2018) | |||
1-225886901-C-T | Likely benign (Oct 23, 2018) | |||
1-225886908-T-G | not specified | Uncertain significance (Sep 25, 2024) | ||
1-225886914-G-T | not specified | Uncertain significance (Jun 16, 2023) | ||
1-225886926-G-A | not specified | Uncertain significance (May 17, 2023) | ||
1-225886926-G-T | not specified | Uncertain significance (Mar 19, 2024) | ||
1-225886936-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
1-225886944-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
1-225886984-C-T | not specified | Uncertain significance (Apr 22, 2024) | ||
1-225886991-C-A | not specified | Likely benign (Mar 20, 2024) | ||
1-225886993-C-T | Benign (Jun 27, 2018) | |||
1-225887034-C-T | not specified | Uncertain significance (Jul 14, 2024) | ||
1-225887035-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
1-225887070-G-A | not specified | Uncertain significance (May 16, 2022) | ||
1-225887072-G-T | not specified | Uncertain significance (Sep 13, 2022) | ||
1-225887074-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
1-225887409-C-A | not specified | Uncertain significance (May 14, 2024) | ||
1-225887412-G-A | not specified | Uncertain significance (May 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LEFTY1 | protein_coding | protein_coding | ENST00000272134 | 4 | 25101 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.68e-13 | 0.0113 | 125675 | 1 | 42 | 125718 | 0.000171 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.738 | 204 | 236 | 0.865 | 0.0000152 | 2306 |
Missense in Polyphen | 56 | 62.647 | 0.89389 | 641 | ||
Synonymous | 1.42 | 97 | 117 | 0.832 | 0.00000828 | 799 |
Loss of Function | -0.603 | 17 | 14.5 | 1.17 | 7.78e-7 | 134 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000410 | 0.000409 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000517 | 0.0000462 |
European (Non-Finnish) | 0.000154 | 0.000150 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000233 | 0.000229 |
Other | 0.000509 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Required for left-right axis determination as a regulator of LEFTY2 and NODAL.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Cell Differentiation - Index expanded;Cell Differentiation - Index;Differentiation Pathway;Mesodermal Commitment Pathway;TGF-beta Receptor Signaling;Developmental Biology;Regulation of signaling by NODAL;Signaling by NODAL
(Consensus)
Recessive Scores
- pRec
- 0.472
Intolerance Scores
- loftool
- 0.538
- rvis_EVS
- 1.42
- rvis_percentile_EVS
- 94.86
Haploinsufficiency Scores
- pHI
- 0.520
- hipred
- N
- hipred_score
- 0.187
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.197
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lefty1
- Phenotype
- cellular phenotype; growth/size/body region phenotype; respiratory system phenotype; liver/biliary system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;heart morphogenesis;transforming growth factor beta receptor signaling pathway;determination of left/right symmetry;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;regulation of apoptotic process;regulation of MAPK cascade;cell development;SMAD protein signal transduction
- Cellular component
- extracellular space
- Molecular function
- cytokine activity;transforming growth factor beta receptor binding;growth factor activity